Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SugarDown in Type 2 Diabetes on Metformin
NCT02135549Completed
- Sponsor
- Boston Therapeutics, Inc.
- Start
- May 2014
- Primary completion
- Oct 2014
- Countries
- 1
01
Overview
Randomised, double-blind trial (3 arms), sponsored by Boston Therapeutics, Inc. Primary endpoint: Postprandial serum glucose area under the curve at 4 hours. Started May 2014; status: completed.
Beyond the preview
Go deeper on NCT02135549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02135549.